![Roy Golan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Golan
Direktor/Vorstandsmitglied bei
NEUROSENSE THERAPEUTICS LTD.
Vermögen: 141 353 $ am 31.05.2026
Profil
Roy Golan currently works at Neurosense Therapeutics Ltd., as Independent Director from 2024, My Size, Inc., as Independent Director from 2025, LIVEKIDNEY.BIO, as Chief Financial Officer from 2025, and Biosight Therapeutics, Inc., as Chief Financial Officer.
Mr. Golan also formerly worked at On Track Innovations Ltd., as Controller, PricewaterhouseCoopers (Israel), as Senior Consultant, G.I.
View Ltd., as Vice President-Finance in 2008, Meridian Bioscience Israel Ltd., as President & Chief Financial Officer from 2018 to 2019, Lifeward Ltd., as Chief Financial Officer, KCS Ltd., as Chief Financial Officer in 2012, BioSight Ltd., as Chief Financial Officer & Executive Vice President from 2019 to 2023, NeuroDerm Ltd., as Chief Financial Officer from 2015 to 2018, and Ayala Pharmaceuticals, Inc., as Chief Financial Officer from 2023 to 2024.
Mr. Golan received his graduate degree from Bar-Ilan University and undergraduate degree from The College of Management Academic Studies.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2026 | 160’844 ( 0.46% ) | 132 053 $ | 31.05.2026 | |
MY SIZE, INC. 0.31% | 15.12.2025 | 15’000 ( 0.31% ) | 9 300 $ | 31.05.2026 |
Aktive Positionen von Roy Golan
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 01.07.2024 |
| MY SIZE, INC. | Direktor/Vorstandsmitglied | 06.03.2025 |
LIVEKIDNEY.BIO
 LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to prevent progression of chronic kidney diseases | Finanzdirektor/CFO | 01.03.2025 |
Ehemalige bekannte Positionen von Roy Golan
| Unternehmen | Position | Ende |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 25.06.2024 |
BioSight Ltd.
 BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Finanzdirektor/CFO | 01.01.2023 |
| EXALENZ BIOSCIENCE LTD | Finanzdirektor/CFO | 29.01.2019 |
| NEURODERM LTD | Finanzdirektor/CFO | 01.04.2018 |
KCS Ltd.
 KCS Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, and payroll services | Finanzdirektor/CFO | 01.01.2012 |
Ausbildung von Roy Golan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
On Track Innovations Ltd.
 On Track Innovations Ltd. Information Technology ServicesTechnology Services Designs, develops and markets cashless payment solutions | Technology Services |
My Size, Inc.
 My Size, Inc. Internet Software/ServicesTechnology Services Engages in the development of smart phone application | Technology Services |
Bar-Ilan University
 Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Israel)
 PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
G.I. View Ltd.
 G.I. View Ltd. Medical SpecialtiesHealth Technology Develops endoscopy products for gastrointestinal applications | Health Technology |
Meridian Bioscience Israel Ltd.
 Meridian Bioscience Israel Ltd. Medical SpecialtiesHealth Technology Manufactures gastrointestinal diagnostic systems for diagnosing and managing in the fields of liver and GI health | Health Technology |
ReWalk Robotics Ltd.
 ReWalk Robotics Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets walk restoration devices | Health Technology |
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
The College of Management Academic Studies
 The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KCS Ltd.
KCS Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, and payroll services | Commercial Services |
LIVEKIDNEY.BIO
LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to prevent progression of chronic kidney diseases | Commercial Services |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Ayala Pharmaceuticals, Inc.
 Ayala Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops cancer therapeutics | Health Technology |
